Our study reveals a negative functional loop, the Fbw7-mediated LDHA/lactate/miR-223 axis, and our findings may constitute a promising therapeutic target for ABC-DLBCL patients. This evidence concerns the gene FBXW7 and diffuse large B-cell lymphoma.